Analysis of IL-6 measurement in patients with GCA treated with tocilizumab should consider concomitant treatment with prednisone

Ann Rheum Dis. 2020 Aug;79(8):e102. doi: 10.1136/annrheumdis-2019-215697. Epub 2019 May 29.

Authors

Maxime Samson^{1

2}, Bernard Bonnotte^{3

2}

Affiliations

¹ Department of Internal Medicine and Clinical Immunology, François Mitterrand Hospital, Dijon University Hospital, Dijon, France samsonmaxime@gmail.com.
² INSERM UMR1098, University of Burgundy, Dijon, France.
³ Department of Internal Medicine and Clinical Immunology, François Mitterrand Hospital, Dijon University Hospital, Dijon, France.

PMID: 31142476
DOI: 10.1136/annrheumdis-2019-215697

No abstract available

Keywords: IL-6; giant cell arteritis; tocilizumab.

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antibodies, Monoclonal, Humanized
Giant Cell Arteritis*
Humans
Infections*
Interleukin-6
Prednisone
Recurrence

Substances

Antibodies, Monoclonal, Humanized
Interleukin-6
tocilizumab
Prednisone